Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma

Clinical trial NCT00471887 · COMPLETED

Trial details

NCT number: NCT00471887
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2007-01-01
Primary completion: 2011-07-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.